The 11th evaluated enterprise of amlodipine besylate tablets was born Chongqing Yaoyou.
-
Last Update: 2019-09-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On September 9, Fosun Pharmaceutical announced that amlodipine besylate tablets of its subsidiary Chongqing Yaoyou pharmaceutical passed the consistency evaluation Amlodipine besylate tablets are mainly used in the treatment of hypertension and coronary heart disease The announcement shows that in 2018, there was no sales volume of amlodipine youbenzenesulfonate tablets in China (excluding Hong Kong, Macao and Taiwan, the same below) At present, amlodipine besylate tablets that have been listed in China mainly include luohuoxi of Dalian Pfizer Pharmaceutical Co., Ltd and yeshida of China Resources SECCO Pharmaceutical Co., Ltd According to the latest data of iqviachpa, in 2018, the sales volume of amlodipine besylate tablets in China was about 2.75 billion yuan According to Yaozhi data, up to now, 11 enterprises including Chongqing Yaoyou have passed the consistency evaluation, and Chongqing Yaoyou is the 11th enterprise.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
